<DOC>
	<DOCNO>NCT02825992</DOCNO>
	<brief_summary>Post Market Clinical Follow-up Study design evaluate incidence device- procedure-related safety , efficacy , efficiency ( 6 12 month outcome ) use AcQMap™ image map system ablation persistent atrial fibrillation ( AF ) .</brief_summary>
	<brief_title>Utilizing Novel Dipole Density Capabilities Objectively Visualize Etiology Rhythms Atrial Fibrillation</brief_title>
	<detailed_description>A prospective , single-arm , multi-center , multi-national , non-randomized , post-market study design provide clinical data regard use AcQMap™ System ablation persistent atrial fibrillation .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Scheduled ablation persistent atrial fibrillation Any duration continuous AF lasting longer 12 month Previous AF ablation Significant structural heart disease Previous cerebral infarct Major bleed disorder Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>